BRIEF-Imara gets orphan drug designation for sickle cell disease drug

* Imara receives orphan drug designation for lead product candidate IMR-687 for sickle cell disease Source text for Eikon: Further company coverage: [Source]

Publication Date: Thursday, 2 February 2017 at 15:23:26

Origin: reuters.com

Category: financialsSector

Topics: sickle, designation, orphan, coverage, company, Further, Eikon, disease Source, IMR-687, product candidate, receives, Imara, disease, BRIEF-Imara

Source: http://feeds.reuters.com/~r/reuters/financialsNews/~3/V9531eUq1c8/idUSFWN1FN0OF

Fitch Rates Lloyd's GBP300m Dated Subordinated Notes 'A-'

[ reuters.com ] financialsSector, Thursday, 2 February 2017 at 18:09:44

UPDATE 1-U.S. House speaker: Tax overhaul to come later this year

[ reuters.com ] financialsSector, Thursday, 2 February 2017 at 18:08:15

BRIEF-CROWN CAPITAL INCREASES QUARTERLY DIVIDEND TO $0.12 PER SHARE

[ reuters.com ] financialsSector, Thursday, 2 February 2017 at 18:03:07

UPDATE 1-Russia approves privatisation plan aimed at raising 17 bln rbls

[ reuters.com ] financialsSector, Thursday, 2 February 2017 at 18:01:08

BRIEF-Turkiye Is Bankasi 2016 net profit up at 4.70 billion lira

[ reuters.com ] financialsSector, Thursday, 2 February 2017 at 17:59:23

Analyzed News